Posted by ABMN Staff on Mar 28th, 2024
BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 20,100 shares, a drop of 60.0% from...
More of this article »